key: cord-0688222-gbjghf68 authors: Marasco, Daniela; Vicidomini, Caterina; Krupa, Pawel; Cioffi, Federica; Quoc Huy, Pham Dinh; Suan Li, Mai; Florio, Daniele; Broersen, Kerensa; De Pandis, Maria Francesca; Roviello, Giovanni N. title: Plant isoquinoline alkaloids as potential neurodrugs: A comparative study of the effects of benzo[c]phenanthridine and berberine based compounds on β-amyloid aggregation date: 2020-10-22 journal: Chem Biol Interact DOI: 10.1016/j.cbi.2020.109300 sha: 07a01233d2da355bf1abeb24fd61cb96091432aa doc_id: 688222 cord_uid: gbjghf68 Herein we present a comparative study of the effects of isoquinoline alkaloids belonging to benzo [c]phenanthridine and berberine families on β-amyloid aggregation. Results obtained using a Thioflavine T (ThT) fluorescence assay and circular dichroism (CD) spectroscopy suggested that the benzo [c]phenanthridine nucleus, present in both sanguinarine and chelerythrine molecules, was directly involved in an inhibitory effect of Aβ(1–42) aggregation. Conversely, coralyne, that contains the isomeric berberine nucleus, significantly increased propensity for Aβ(1–42) to aggregate. Surface Plasmon Resonance (SPR) experiments provided quantitative estimation of these interactions: coralyne bound to Aβ(1–42) with an affinity (K(D) = 11.6 μM) higher than benzo [c]phenanthridines. Molecular docking studies confirmed that all three compounds are able to recognize Aβ(1–42) in different aggregation forms suggesting their effective capacity to modulate self-recognition mechanism. Molecular dynamics simulations indicated that coralyne increased the β-content of Aβ(1–42), in early stages of aggregation, consistently with fluorescence-based promotion of self-recognition mechanism by this alkaloid. At the same time, sanguinarine seemed to determine an increase of helical conformation corroborating its ability to delay aggregation as experimentally proved in vitro. Investigated compounds demonstrated to interfere with aggregation of Aβ(1–42) applying as starting leads in neurodegenerative diseases. Several neurodegenerative disorders, including Alzheimer's (AD), Parkinson's (PD) and 49 Huntington's (HD) diseases are associated with aggregation of misfolded proteins [1, 2] . Among which alone is able to aggregate into insoluble fibrils, and a hydrophobic C-terminal region 56 (residues 23-42). Once released as a monomer from APP into extracellular space, Aβ 1-42 undergoes 57 a structural transition gaining β-sheet content, and tends to aggregate into oligomeric, protofibrillar 58 and fibrillar species [7] . Aβ 1-42 oligomeric assemblies have been related to AD pathogenesis for 59 their role in neuronal damage and neurotoxicity following Aβ 1-42 aggregation [8] . In this context, 60 preventing Aβ 1-42 aggregation with small molecules is one of the prominent strategies for the 61 development of new therapies for AD [9] [10] [11] . To this scope, several plant extracts and natural 62 products, such as curcumin, epigallocatechin-3-gallate, and resveratrol, were evaluated with [19, 20] . However, its use as a neurodrug is hampered by its cytotoxic effects at relatively 71 high concentration [21] . Hence, a structurally modified version of berberine that results in the free 72 hydroxyl-bearing Ber-D was prepared, which was found to inhibit the aggregation and cell toxicity 73 of Aβ in vitro [22] . The berberine nucleus in Ber-D comprises four rings, of which three 74 aromatic, whereas the anti-leukemic berberine-like drug coralyne (here indicated as CO, Figure 1 ) 75 contains all four aromatic rings [23, 24] . 76 Other examples of plant isoquinoline alkaloids are sanguinarine (SA) and chelerythrine (CH, Figure 77 1), two tetracyclic aromatic compounds isolated from Macleaya cordata belonging to the family of 78 benzo[c]phenanthridines, and also classifiable as azachrysenes [25, 26] The scope of this work was to investigate the interaction between tetracyclic aromatic structures 98 endowed with benzo[c]phenanthridine (SA, CH) and berberine nuclei, respectively (CO, Figure 1 ) 99 with Aβ 1-42 peptide, by means of ThT fluorescence and CD spectroscopies to evaluate their effects 100 on the aggregation of Aβ 1-42, and by SPR assays to evaluate the entity of these interactions. Experimental data were further corroborated by in silico studies, through molecular docking 102 simulations, to unveil preferential binding modes of ligands to different aggregated forms of Aβ 1-42 , 103 and by molecular dynamics simulations to deepen the effects of these compounds in early 104 aggregation stages of Aβ 1-42 . The CD experiments were conducted as previously described [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] . The spectra were obtained 132 using a JascoJ-715 spectropolarimeter coupled to a PTC-348WI temperature control system, and a 133 quartz cell with a path length of 1 cm, at 37 • C with a response of 1 s, a scanning speed of 100 134 nm/min and a 2.0 nm bandwidth. All the spectra were averaged over three scans. Experiments were In all computational studies, as initial Aβ 1-42 conformations we utilized S-shape and U-shape fibril where ΔE elec and ΔE vdW are differences in electrostatic and van der Waals energy components, 207 respectively, ΔE SUR and ΔE PB describe differences in non-polar and polar solvation free energies, 208 respectively, and TΔS represents the entropic contribution. In this study, MM/PBSA methods implemented into the AmberTools 19 package was used 210 to estimate ΔG bind of compounds to fibrillar models using second halves of performed MD The observed changes, impacting on both intensity and shape of spectra, were already described by 344 As oligomeric states are a bridging step between monomers and fibrils, we decided to study the Table 5 ). With binding energies ranging from -10.4 to -12.2 kcal/mol (Table 5) Table S2 ). chains, and destabilized β-strands (much larger variation with SA on Figure S6 and Table 6 ). This between chains, confirming that compounds are able to directly interact with the single Aβ 1-42 408 chains, to alter the equilibrium between monomeric and oligomeric forms ( Figure S7 ). Amyloid fibrillogenesis: themes and variations, Current Opinion in Structural 462 Alzheimer's Disease: When Computer Simulations Complement Experimental Studies Current understanding of Alzheimer's disease diagnosis and treatment Alzheimer's disease, The Lancet Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils Oligomeric Aβ in Alzheimer's Disease: Relationship to 474 Plaque and Tangle Pathology Aβ42 477 Neurotoxicity Is Mediated by Ongoing Nucleated Polymerization Process Rather than by Discrete Aβ42 478 Species Increased cholesterol in Aβ-positive nerve terminals 480 from Alzheimer's disease cortex Inhibition of protein aggregation and amyloid formation by small molecules, 482 Current Opinion in Structural Biology Beta Amyloid Aggregation 484 Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimers Disease, Current medicinal 485 chemistry Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative 488 and anti-amyloid lead compound the Presence of Naturally Occurring Phenolic Inhibitors Using Coarse-Grained Simulations Potential Lead for Alzheimer's Disease: In Silico and In Vitro Study Curcumin Binds to Aβ1-40 Peptides and Fibrils Stronger Than Ibuprofen and 494 Antiviral and Antimicrobial Profiles of Selected Isoquinoline 497 Alkaloids from Fumaria and Corydalis Species Hepatoprotective 499 effect of berberine against methotrexate induced liver toxicity in rats Isoquinoline alkaloids of Zanthoxylum quinduense (Rutaceae) Berberine 504 prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with 505 Parkinson's disease Berberine and 507 neurodegeneration: A review of literature Neurotoxic effects of berberine 509 on long-term l-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease, 510 Antioxidant Berberine-512 Derivative Inhibits Multifaceted Amyloid Toxicity, iScience Experimental antileukemic agents. Coralyne, analogs, and 514 related compounds Molecular recognition of nucleic acids: Coralyne binds 516 strongly to poly(A) Separation of sanguinarine and chelerythrine in Macleaya 518 cordata (Willd) R. Br. based on methyl acrylate-co-divinylbenzene macroporous adsorbents Quaternary benzo[c]phenanthridine alkaloids, Collection of Czechoslovak 521 Chemical Communications Dietary sanguinarine affected immune 523 response, digestive enzyme activity and intestinal microbiota of Koi carp (cryprinus carpiod) Serum amyloid A, the major vertebrate acute-phase reactant Serum amyloid A (SAA)-induced remodeling of CSF-HDL Serum Amyloid A is a 531 biomarker of severe Coronavirus Disease and poor prognosis Comorbidities and multi-organ injuries in the 533 treatment of COVID-19 The epidemiology and pathogenesis of coronavirus disease (COVID-19) 535 outbreak SARS CoV-2: Recent Reports on Antiviral Therapies Based 537 on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other 538 Drugs for the Treatment of the New Coronavirus Lower COVID-19 mortality in Italian forested areas suggests 540 immunoprotection by Mediterranean plants Lead compounds from medicinal plants for the treatment of neurodegenerative diseases 544 Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and 545 beta amyloid aggregation: The case of chelerythrine Top-leads from natural products for treatment of Alzheimer's disease: docking and 548 molecular dynamics study A standardized and biocompatible preparation of aggregate-free amyloid beta peptide for 551 biophysical and biological studies of Alzheimer's disease Synthesis of a l-lysine-based alternate 554 alpha,epsilon-peptide: a novel linear polycation with nucleic acids-binding ability Synthesis, spectroscopic 557 studies and biological activity of a novel nucleopeptide with Moloney murine leukemia virus reverse 558 transcriptase inhibitory activity Solid phase synthesis of TyrT, a thymine-tyrosine 560 conjugate with poly(A) RNA-binding ability Synthesis of a 562 novel Fmoc-protected nucleoaminoacid for the solid phase assembly of 4-piperidyl glycine/l-arginine-563 containing nucleopeptides and preliminary RNA interaction studies Novel insights into nucleoamino acids: biomolecular recognition and aggregation studies 565 of a thymine-conjugated l-phenyl alanine Spectroscopic and SEM evidences for G4-DNA binding by a synthetic alkyne-568 containing amino acid with anticancer activity Synthesis and nucleic acid binding evaluation of a thyminyl L-571 diaminobutanoic acid-based nucleopeptide Synthesis of 573 quadruplex-forming tetra-end-linked oligonucleotides: effects of the linker size on quadruplex topology and 574 stability Thiophenyl-substituted triazolyl-thione l-alanine: asymmetric synthesis, aggregation and biological 577 properties Synthesis, characterization and hybridization studies of new nucleo-gamma-580 peptides based on diaminobutyric acid Evaluating the biological properties of synthetic 4-nitrophenyl functionalized benzofuran 583 derivatives with telomeric DNA binding and antiproliferative activities Properties of monomeric Aβ42 probed by different sampling methods 586 and force fields: Role of energy components Fast, efficient generation of high-quality atomic charges. AM1-BCC 598 model: II. Parameterization and validation Development and testing of a general 600 amber force field AutoDock4 and 602 AutoDockTools4: Automated docking with selective receptor flexibility Autodock Vina Adopts More Accurate Binding Poses but Autodock4 Forms Better Binding Affinity Simmerling, ff14SB: Improving the 608 Accuracy of Protein Side Chain and Backbone Parameters from ff99SB Comparison of simple potential 611 functions for simulating liquid water Amino-Acid-Specific Protein Backbone Parameters Trained against Quantum 614 Building Water Models: A Different Approach Approximate atomic surfaces from linear combinations of pairwise 618 overlaps (LCPO) Dictionary of protein secondary structure: Pattern recognition of hydrogen-620 bonded and geometrical features Multiscale Molecular Dynamics Simulations Thioflavin T Stain: An Easier and More Sensitive Method for Amyloid 625 Detection Amyloid-beta peptide Aβp3-42 affects early aggregation of full-length 627 Nucleophosmin contains amyloidogenic regions 630 that are able to form toxic aggregates under physiological conditions The relationship 632 between the aggregational state of the amyloid-β peptides and free radical generation by the peptides Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity High-resolution NMR characterization of low 639 abundance oligomers of amyloid-beta without purification Brazilin inhibits fibrillogenesis of human islet amyloid polypeptide, 641 disassembles mature fibrils, and alleviates cytotoxicity Coffee Components Inhibit Amyloid Formation of Human Islet Amyloid Polypeptide in Vitro: Possible Link 644 between Coffee Consumption and Diabetes Mellitus Silibinin inhibits the toxic 647 aggregation of human islet amyloid polypeptide Toward the Molecular Mechanism(s) by Which EGCG 650 Treatment Remodels Mature Amyloid Fibrils Engineered β-653 hairpin scaffolds from human prion protein regions: Structural and functional investigations of aggregates Structural insights into amyloid structures of the C-terminal region of nucleophosmin 1 in 657 type A mutation of acute myeloid leukemia Platinum(II) O,S Complexes Inhibit the Aggregation of Amyloid Model 661 Systems Role of the Metal Center in the 663 Modulation of the Aggregation Process of Amyloid Model Systems by Square Planar Complexes Bearing 2-664 (2'-pyridyl)benzimidazole Ligands Destabilisation, aggregation, toxicity and cytosolic mislocalisation of 667 nucleophosmin regions associated with acute myeloid leukemia The acute myeloid leukemia-associated 670 Nucleophosmin 1 gene mutations dictate amyloidogenicity of the C-terminal domain Inhibitors of the apurinic/apyrimidinic endonuclease 1 673 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties Polypharmacology of Berberine Based on Multi-Target Binding Motifs, Frontiers in 677 Pharmacology Substantial Contribution of the Two Imidazole Rings of the His13−His14 Dyad to 679 Binding in Amyloid-β(1−16) at Physiological pH and Its Significance, The Journal of Physical Chemistry 680 A Amyloid-β protein oligomerization and the importance of 683 tetramers and dodecamers in the aetiology of Alzheimer's disease Amyloid β-Protein Fibrillogenesis The Alzheimer's Peptide Aβ Adopts a Collapsed Coil Structure in Water Alzheimer Amyloid-β Aβ16−22 Protofilaments Prediction of fibril formation by early-stage amyloid peptide 694 aggregation Targeting Amyloid Aggregation: An Overview of Strategies 696 and Mechanisms Aggregation rate of amyloid beta peptide is controlled by beta-698 content in monomeric state Interference with Amyloid-β Nucleation 700 by Transient Ligand Interaction Assembly of Amyloid Protofibrils via Critical Oligomers-702 A Novel Pathway of Amyloid Formation Highlights • We compared the effects of three isoquinoline alkaloids on β-amyloid aggregation • Sanguinarine and chelerythrine showed inhibitory effects on Aβ1-42 aggregation • Coralyne significantly increased propensity for Aβ1-42 to aggregate • Molecular dynamics suggested the alkaloid ability to affect β-content of J o u r n a l P r e -p r o o f ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:J o u r n a l P r e -p r o o f